Key result
Intravenous administration of 5.0 mg of glucagon resulted in significant cardiac inotropic effects in 16 digitalized patients on the first postoperative day after prosthetic valve replacement.
Why the study?
Does intravenous glucagon improve cardiac inotropic effects in digitalized patients following prosthetic valve replacement?
Population
16 digitalized patients on the first postoperative day after prosthetic valve replacement
Design
Case_series
Follow-up
first postoperative day
Authors
Loading...
May suggest glucagon as inotrope in digitalized post-valve patients; hypothesis-generating and should not yet change practice.
Does intravenous glucagon improve cardiac inotropic effects in digitalized patients following prosthetic valve replacement?
Intravenous glucagon provides significant inotropic effects with little arrhythmogenic potential in postoperative cardiac surgery patients.
Parmley et al. (1969) studied Postoperative prosthetic valve replacement (n=16). Glucagon was evaluated on Cardiac inotropic effects. Intravenous administration of 5.0 mg of glucagon resulted in significant cardiac inotropic effects in 16 digitalized patients on the first postoperative day after prosthetic valve replacement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: